Total Payments
$3,686
2024 Payments
$873.31
Companies
22
Transactions
124
Medicare Patients
3,956
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$3,577 (97.0%)
Education$109.09 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,577 | 122 | 97.0% |
| Education | $109.09 | 2 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $584.50 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $471.41 | 22 | $0 (2024) |
| Philips Electronics North America Corporation | $399.01 | 20 | $0 (2023) |
| GENZYME CORPORATION | $340.06 | 6 | $0 (2024) |
| Baxter Healthcare | $325.05 | 11 | $0 (2024) |
| Mylan Specialty L.P. | $302.41 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $245.89 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $148.67 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $104.49 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $873.31 | 30 | Mylan Specialty L.P. ($113.53) |
| 2023 | $620.37 | 24 | Baxter Healthcare ($213.86) |
| 2022 | $453.53 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($151.76) |
| 2021 | $244.68 | 12 | GlaxoSmithKline, LLC. ($68.89) |
| 2020 | $55.58 | 3 | Philips Electronics North America Corporation ($26.55) |
| 2019 | $665.74 | 20 | Amgen Inc. ($241.78) |
| 2018 | $601.06 | 14 | Amgen Inc. ($245.15) |
| 2017 | $171.55 | 3 | E.R. Squibb & Sons, L.L.C. ($125.00) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/05/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Medical Device | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $21.51 | General |
| Category: Medical Device | ||||||
| 10/17/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Airway Clearance Device | ||||||
| 10/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $34.52 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $97.57 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Immunology | ||||||
| 08/02/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $26.09 | General |
| Category: Medical Device | ||||||
| 07/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/20/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Airway Clearance Device | ||||||
| 06/06/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 05/30/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/22/2024 | SANOFI-AVENTIS U.S. LLC | KEVZARA (Biological) | Education | In-kind items and services | $90.00 | General |
| Category: Rheumatology | ||||||
| 05/16/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: PULMONOLOGY | ||||||
| 05/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Medical Device | ||||||
| 04/04/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $34.88 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,008 | 5,266 | $1.1M | $503,564 |
| 2022 | 10 | 1,004 | 4,959 | $927,075 | $413,098 |
| 2021 | 10 | 954 | 6,111 | $1.2M | $549,258 |
| 2020 | 8 | 990 | 6,665 | $1.2M | $565,523 |
Total Patients
3,956
Total Services
23,001
Medicare Billing
$2.0M
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 180 | 2,318 | $301,340 | $153,334 | 50.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 86 | 716 | $330,792 | $126,391 | 38.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 184 | 751 | $138,935 | $74,568 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 258 | 522 | $104,665 | $52,246 | 49.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 16 | 422 | $67,844 | $38,126 | 56.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 164 | 194 | $69,840 | $28,043 | 40.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 14 | 237 | $35,122 | $20,960 | 59.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $23,700 | $9,710 | 41.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 27 | 27 | $621.00 | $187.22 | 30.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 220 | 3,252 | $426,670 | $194,481 | 45.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 91 | 477 | $220,374 | $87,196 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 454 | $91,630 | $45,482 | 49.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 183 | 216 | $77,440 | $35,798 | 46.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 106 | 256 | $47,360 | $22,193 | 46.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $30,300 | $12,521 | 41.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 12 | 124 | $18,848 | $9,594 | 50.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 15 | 16 | $4,800 | $2,240 | 46.7% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 11 | 15 | $4,500 | $2,092 | 46.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 17 | $4,440 | $1,229 | 27.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 31 | 31 | $713.00 | $270.83 | 38.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 239 | 3,719 | $483,802 | $227,362 | 47.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 89 | 904 | $417,648 | $168,835 | 40.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 80 | 518 | $95,830 | $41,985 | 43.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 210 | 230 | $82,800 | $38,989 | 47.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 160 | 299 | $60,500 | $33,218 | 54.9% |
About Dr. Adel Sandouk, M.D
Dr. Adel Sandouk, M.D is a Pulmonary Disease healthcare provider based in Glendora, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043315575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adel Sandouk, M.D has received a total of $3,686 in payments from pharmaceutical and medical device companies, with $873.31 received in 2024. These payments were reported across 124 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,577).
As a Medicare-enrolled provider, Sandouk has provided services to 3,956 Medicare beneficiaries, totaling 23,001 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Glendora, CA
- Active Since 09/13/2006
- Last Updated 01/12/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1043315575
Products in Payments
- Enbrel (Biological) $366.78
- TRELEGY ELLIPTA (Drug) $301.23
- KEVZARA (Drug) $249.73
- DUPIXENT (Biological) $239.00
- YUPELRI (Drug) $197.32
- (8874) inCourage (Device) $148.62
- ELIQUIS (Drug) $125.00
- Prolia (Biological) $120.15
- OFEV (Drug) $118.57
- Hillrom - MetaNeb System (Device) $117.94
- inCourage (Device) $115.03
- STIOLTO RESPIMAT (Drug) $107.99
- Yupelri (Drug) $105.09
- Arikayce (Drug) $98.52
- Otezla (Drug) $97.57
- Wellcentive Undiv (Device) $93.60
- KEVZARA (Biological) $90.00
- Hillrom - Vest System Model 105 Home Care (Device) $87.62
- Hillrom - Life 2000 Ventilation System (Device) $84.70
- CHARTIS CATHETER (Device) $75.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.